Quantum Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,842
Closed -$268K 186
2022
Q1
$268K Buy
5,842
+200
+4% +$9.54K 0.12% 152
2021
Q4
$345K Buy
+5,642
New +$390K 0.13% 142

Other funds holding ARKG

Quantum Private Wealth's ARKG Position: Q2 2022 in Review

Quantum Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,842 shares — an estimated $268K sold.

Quantum Private Wealth first reported a position in ARKG in Q4 2021 and held it in 2 quarters. The position peaked at $345K in Q4 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Quantum Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Quantum Private Wealth sold 5,842 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $268K.
  • Quantum Private Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 2 quarters.
  • Quantum Private Wealth's ARK Genomic Revolution ETF position peaked at $345K in Q4 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Quantum Private Wealth's 13F filing for Q2 2022, filed 17 Aug 2022.